We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02580955
Recruitment Status : Unknown
Verified August 2018 by Flanders Medical Research Program.
Recruitment status was:  Active, not recruiting
First Posted : October 20, 2015
Last Update Posted : August 13, 2018
Information provided by (Responsible Party):
Flanders Medical Research Program

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : January 2019